Clinical Trial Update: A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm [Phase 2]

View source ↗

Summary

Phase 2 trial assessing NT 201 (Botulinum Toxin) versus placebo for essential tremor in the upper limb has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor of the Upper Limb

Drugs mentioned

• NT 201

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Essential Tremor of the Upper Limb | Phase 2 | Status: COMPLETED